Abstract:1 Recent work in our laboratory has demonstrated that intrathecal administration of a selective antagonist of calcitonin gene-related peptide (CGRP), CGRP(8-37), increased the hindpaw withdrawal latency (HWL) to thermal stimulation and hindpaw withdrawal threshold (HWT) to pressure in normal rats, and that these effects were more pronounced than in rats with mononeuropathy. 2 The present study was performed to investigate the effects of intrathecal administration of CGRP(8-37) on the HWL and HWT in rats with unilateral hindpaw inflammation induced by subcutaneous injection of carrageenin. The effect of naloxone was also studied. 3 Subcutaneous injection of 0.1 ml of carrageenin into the plantar region of the left hindpaw induced a significant increase in the volume of the ipsilateral hindpaw (P< 0.001), and significant bilateral decreases of the HWL to thermal stimulation (ipsilateral: P<0.001; contralateral: P<0.01) and HWT to pressure (ipsilateral: P<0.001; contralateral: P<0.01). 4 Intrathecal administration of 10 nmol of CGRP(8-37), but not of 1 or 5 nmol, induced a significant bilateral increase in the HWL and HWT in rats with experimentally induced inflammation (thermal test: P<0.001; mechanical test: P<0.001). 5 The effect of intrathecal administration of 10 nmol CGRPB(8-37) on HWL and HWT was significantly more pronounced in intact rats than in rats with experimentally induced inflammation (ipsilateral: P<0.001; contralateral: P<0.001). 6 The effect of CGRP(8-37) on withdrawal responses in the inflamed paw was partly reversed by intrathecal injection of naloxone at a dose of 88 nmol in the thermal (ipsilateral: P<0.01; contralateral: P=0.14) and mechanical tests (ipsilateral: P<0.05; contralateral: P=0.60). 7 A significant bilateral increase in the concentration of CGRP-like immunoreactivity in the perfusate of both hindpaws was demonstrated 24 h after unilateral injection of carrageenin (ipsilateral: P<0.001; contralateral: P<0.05). There was also an increase in the amount of CGRP-like immunoreactivity in the cerebrospinal fluid (P<0.001), but not in plasma (P=0.75). 8 The present study demonstrates that acute experimentally-induced unilateral hindpaw inflammation, induces bilateral increases in the amount of CGRP-like immunoreactivity in hindpaw perfusates. Intrathecal administration of CGRP(8-37) increased the HWL to thermal stimulation and HWT to pressure bilaterally. 9 The results indicate that CGRP plays a role in the transmission of presumed nociceptive information in the spinal cord of rats with experimentally induced inflammation. Furthermore, our findings suggest that opioids can modulate CGRP-related effects in the spinal cord.

Involvement of CGRP and CGRP1 receptor in nociception in the nucleus accumbens of rats.

Involvement of Opioid Receptors in the CGRP-induced Antinociception in the Nucleus Accumbens of Rats

Involvement of calcitonin gene-related peptide and its receptor in anti-nociception in the periaqueductal grey of rats.

Anti-nociceptive effects of calcitonin gene-related peptide in nucleus raphe magnus of rats: an effect attenuated by naloxone.

Galanin Receptor 1 Plays an Antinociceptive Effect Via Inhibiting PKA Activation in the Nucleus Accumbens of Rats with Neuropathic Pain

Intrathecal CGRP(8-37)-induced bilateral increase in hindpaw withdrawal latency in rats with unilateral inflammation

Involvement of opioid receptors in the CGRP8-37-induced inhibition of the activity of wide-dynamic-range neurons in the spinal dorsal horn of rats.

Intrathecal CGRP8–37 results in a bilateral increase in hindpaw withdrawal latency in rats with a unilateral thermal injury

Antinociceptive Effects of Calcitonin Gene-Related Peptide Injected into Periaqueductal Grey of Rats with Mononeuropathy

Role of Calcitonin Gene-Related Peptide in Nociceptive Modulationin Anterior Cingulate Cortex of Naive Rats and Rats With Inflammatory Pain

Anti-nociceptive effect of neuropeptide Y in the nucleus accumbens of rats: an involvement of opioid receptors in the effect.

Antinociceptive Effect of Calcitonin Gene-Related Peptide in the Central Nucleus of Amygdala: Activating Opioid Receptors Through Amygdala–periaqueductal Gray Pathway

Anti-Nociceptive Role of Neuropeptide Y in the Nucleus Accumbens in Rats with Inflammation, an Effect Modulated by Mu- and Kappa-Opioid Receptors

Opioid Antagonists Naloxone, Β-Funaltrexamine and Naltrindole, but Not Nor-Binaltorphimine, Reverse the Increased Hindpaw Withdrawal Latency in Rats Induced by Intrathecal Administration of the Calcitonin Gene-Related Peptide Antagonist CGRP8–37

Role of corticotropin-releasing factor and its receptor in nociceptive modulation in the central nucleus of amygdala in rats.

Involvement of neuropeptide Y and Y1 receptor in antinociception in nucleus raphe magnus of rats.

The calcitonin gene-related peptide antagonist CGRP8–37 increases the latency to withdrawal responses bilaterally in rats with unilateral experimental mononeuropathy, an effect reversed by naloxone

Opioids Modulate the Calcitonin Gene-Related Peptide8–37 - Mediated Hindpaw Withdrawal Latency Increase in Thermally Injured Rats

Calcitonin Gene-Related Peptide and Its Receptor Plays Important Role in Nociceptive Regulation in the Arcuate Nucleus of Hypothalamus of Rats with Inflammatory Pain.

Role of calcitonin gene-related peptide in pain regulation in the parabrachial nucleus of naive rats and rats with neuropathic pain

Role of calcitonin gene-related peptide and its antagonist on the evoked discharge frequency of wide dynamic range neurons in the dorsal horn of the spinal cord in rats.